Alpha Tau Medical
DRTS • NASDAQ
Alpha Tau Medical is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Uzi Sofer, with a market cap of $603.7M.
CEOUzi Sofer
Next Earnings
Upcoming earnings announcement for Alpha Tau Medical
Date
Monday, May 18, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.13
Revenue Estimate
$115.8K
Earnings History
Past 12 earnings reports for Alpha Tau Medical
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | Q4 2025 | -$0.14Est: -$0.13 | -7.7% | - | — | — |
| Nov 20, 2025 | Q3 2025 | -$0.14Est: -$0.12 | -16.7% | - | — | — |
| Aug 11, 2025 | Q2 2025 | -$0.13Est: -$0.12 | -8.3% | - | — | — |
| May 19, 2025 | Q1 2025 | -$0.12Est: -$0.13 | +7.7% | - | — | — |
| Mar 12, 2025 | Q4 2024 | -$0.13Est: -$0.13 | 0.0% | - | — | — |
| Nov 19, 2024 | Q3 2024 | -$0.10Est: -$0.12 | +16.7% | - | — | — |
| Aug 14, 2024 | Q2 2024 | -$0.11Est: -$0.12 | +8.3% | -Est: $30.0K | -100.0% | — |
| May 20, 2024 | Q1 2024 | -$0.11Est: -$0.12 | +8.3% | - | — | — |
| Mar 7, 2024 | Q4 2023 | -$0.11Est: -$0.12 | +8.3% | - | — | — |
| Nov 16, 2023 | Q3 2023 | -$0.07Est: -$0.12 | +41.7% | - | — | — |
| Aug 28, 2023 | Q2 2023 | -$0.12Est: -$0.13 | +7.7% | - | — | — |
| May 23, 2023 | Q1 2023 | -$0.12Est: -$0.11 | -9.1% | - | — | — |